Pressure Biosciences Stock Number Of Shares Shorted
Pressure Biosciences fundamentals help investors to digest information that contributes to Pressure Biosciences' financial success or failures. It also enables traders to predict the movement of Pressure OTC Stock. The fundamental analysis module provides a way to measure Pressure Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pressure Biosciences otc stock.
Pressure |
Pressure Biosciences OTC Stock Number Of Shares Shorted Analysis
Pressure Biosciences' Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current Pressure Biosciences Number Of Shares Shorted | 6.34 K |
Most of Pressure Biosciences' fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pressure Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
CompetitionBased on the recorded statements, Pressure Biosciences has 6.34 K of outstending shares currently sold short by investors. This is 99.8% lower than that of the Life Sciences Tools & Services sector and 99.77% lower than that of the Health Care industry. The number of shares shorted for all United States stocks is 99.87% higher than that of the company.
Pressure Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pressure Biosciences' direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Pressure Biosciences could also be used in its relative valuation, which is a method of valuing Pressure Biosciences by comparing valuation metrics of similar companies.Pressure Biosciences is currently under evaluation in number of shares shorted category among its peers.
Pressure Fundamentals
| Return On Asset | -0.93 | ||||
| Operating Margin | (3.18) % | ||||
| Current Valuation | 33.23 M | ||||
| Shares Outstanding | 11.07 M | ||||
| Shares Owned By Insiders | 1.27 % | ||||
| Shares Owned By Institutions | 0.05 % | ||||
| Number Of Shares Shorted | 6.34 K | ||||
| Price To Earning | (1.05) X | ||||
| Price To Sales | 9.95 X | ||||
| Revenue | 2 M | ||||
| Gross Profit | 1.06 M | ||||
| EBITDA | (5.59 M) | ||||
| Net Income | (20.15 M) | ||||
| Cash And Equivalents | 121.57 K | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 150 K | ||||
| Debt To Equity | 2.04 % | ||||
| Current Ratio | 0.07 X | ||||
| Book Value Per Share | (2.44) X | ||||
| Cash Flow From Operations | (4.87 M) | ||||
| Short Ratio | 3.00 X | ||||
| Earnings Per Share | (2.59) X | ||||
| Target Price | 1.57 | ||||
| Number Of Employees | 12 | ||||
| Beta | 0.73 | ||||
| Market Capitalization | 23.22 M | ||||
| Total Asset | 2.83 M | ||||
| Retained Earnings | (81.02 M) | ||||
| Working Capital | 9.2 M | ||||
| Current Asset | 13.07 M | ||||
| Current Liabilities | 3.88 M | ||||
| Z Score | 53.5 | ||||
| Net Asset | 2.83 M |
Pair Trading with Pressure Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Pressure Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pressure Biosciences will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to CH Robinson could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CH Robinson when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CH Robinson - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CH Robinson Worldwide to buy it.
The correlation of CH Robinson is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CH Robinson moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CH Robinson Worldwide moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CH Robinson can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Pressure OTC Stock
If you are still planning to invest in Pressure Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pressure Biosciences' history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |